Press release
Autoimmune Disease Diagnostics Market to Reach USD 8.91 billion by 2030, Driven by Improved Diagnostic Accuracy
Autoimmune Disease Diagnostics Market Size & Trends | Mordor Intelligence
Introduction:
The Autoimmune Disease Diagnostics Market size is estimated at USD 6.17 billion in 2025, and is expected to reach USD 8.91 billion by 2030, at a CAGR of 7.59% during the forecast period (2025-2030). This steady rise reflects global efforts to improve early diagnosis and management of autoimmune conditions through advanced immunoassay technologies and expanding laboratory capacities.
Autoimmune disorders are increasingly recognized as a major public health concern, affecting millions worldwide. The demand for early detection tools and specialized assays continues to grow as patients and healthcare providers seek better management strategies. The market expansion is also driven by an increasing number of clinical laboratories offering multiplex testing, heightened awareness campaigns, and the incorporation of automation in diagnostic workflows.
Report Overview: https://www.mordorintelligence.com/industry-reports/global-autoimmune-disease-diagnostics-market?utm_source=openpr
Key Trends:
The autoimmune disease diagnostics market trends underscore the industry's movement toward accuracy, accessibility, and efficiency. Several factors are shaping its growth trajectory:
Rising Prevalence of Autoimmune Disorders: A steady increase in conditions such as rheumatoid arthritis, lupus, and type 1 diabetes is driving the need for consistent and reliable diagnostic screening. Growing awareness among physicians has led to earlier referrals and testing adoption.
Advances in Immunoassay and Molecular Diagnostics: The introduction of multiplex immunoassays, chemiluminescent assays, and next-generation sequencing methods allows for simultaneous detection of multiple autoantibodies, enhancing result precision and turnaround times.
Increased Point-of-Care Testing: The transition toward decentralized testing solutions enables clinicians to obtain results faster and initiate treatment promptly. Portable and automated platforms are especially gaining traction in outpatient settings.
Collectively, these developments signify steady autoimmune disease diagnostics market growth supported by technological refinement and expanding healthcare ecosystems across both developed and emerging economies.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
https://www.mordorintelligence.com/ja/industry-reports/global-autoimmune-disease-diagnostics-market?utm_source=openpr
Market Segmentation:
The autoimmune disease diagnostics market analysis indicates that segmentation remains diverse, encompassing multiple diagnostic technologies and disease applications. This multi-dimensional approach enables manufacturers and healthcare providers to tailor testing solutions to specific clinical needs.
By Disease Type
Systemic Autoimmune Diseases
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Other Systemic Autoimmune Diseases
By Product and Service
Reagents & Assay Kits
Instruments/Analyzers
Software & Informatics
Services
By Test Type
Antinuclear Antibody (ANA) Tests
Autoantibody Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP)
Urinalysis
Other Tests
By Technology
Enzyme-linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassay (CLIA)
Indirect Immunofluorescence (IFA)
Multiplex Assay Platforms
Flow Cytometry
Other Technologies
By End User
Hospital & Clinical Laboratories
Reference Laboratories
Academic & Research Institutes
Other End Users
By Geography:
North America
Europe
Asia-Pacific
Middle East & Africa
South America
Key Players:
The autoimmune disease diagnostics market is characterized by a mix of global healthcare conglomerates and specialized diagnostic firms. Leading players are focusing on product innovation, mergers, and clinical collaborations to strengthen their presence and meet diverse diagnostic demands.
F. Hoffmann-La Roche AG
Abbott Laboratories
Siemens Healthineers
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Explore more insights on autoimmune disease diagnostics market competitive landscape: https://www.mordorintelligence.com/industry-reports/global-autoimmune-disease-diagnostics-market/companies?utm_source=openpr
Conclusion:
The autoimmune disease diagnostics market analysis reveals that global healthcare systems are prioritizing early detection, personalized medicine, and data-driven diagnosis to improve patient outcomes. The steady rise in autoimmune disease cases worldwide has made diagnostic testing a cornerstone of disease management strategies.
Looking ahead, the autoimmune disease diagnostics market growth will continue to hinge on factors such as affordability of tests, technological advancement in immunoassays, and rising government attention toward chronic disease burden reduction. Companies that can deliver cost-effective, scalable, and reliable diagnostic solutions are poised to thrive in the coming years.
For complete market analysis, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/global-autoimmune-disease-diagnostics-market?utm_source=openpr
Industry Related Reports
North America Autoimmune Disease Diagnostics Market: The North American Autoimmune Disease Diagnostics Market Report is Segmented by Disease Type (Systemic Autoimmune Disease And Localized Autoimmune Disease), Diagnosis Tests (Regular Laboratory Tests, Inflammatory Markers, Immunologic Assays, Antibody Tests, and Other Tests), and Geography (United States, Canada, and Mexico).
Get More Insights: https://www.mordorintelligence.com/industry-reports/north-america-autoimmune-diagnostics-market-industry?utm_source=openpr
Immunoprotein Diagnostic Testing Market: The Immunoprotein Diagnostic Testing Market report segments the industry into By Product Type (Instruments, Kits and Reagents, Other Product Types), By Technology (Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Other Technologies), By Application (Infectious Disease, Endocrine, Toxicology, Other Applications), and Geography (North America, Europe, Asia-Pacific, and more).
Get More Insights: https://www.mordorintelligence.com/industry-reports/immunoprotein-diagnostic-testing-market?utm_source=openpr
Immunofluorescence Assay Market: The Immunofluorescence Assay Market Report is Segmented by Product (Reagents and Kits, Instruments, Accessories), Immunofluorescence Type (Indirect Immunofluorescence, Direct Immunofluorescence), Application (Cancer Diagnostics and Research, and More), End User (Hospital and Reference Laboratories, and More), and Geography (North America, Europe, and More.
Get More Insights: https://www.mordorintelligence.com/industry-reports/immunofluorescence-assay-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Disease Diagnostics Market to Reach USD 8.91 billion by 2030, Driven by Improved Diagnostic Accuracy here
News-ID: 4243335 • Views: …
More Releases from Mordor Intelligence
1,6-Hexanediol Market to Reach USD 1.53 Billion by 2030, Highlights Emerging Tre …
The global 1,6-hexanediol market size is forecast to grow from approximately USD 1.09 billion in 2025 to USD 1.53 billion by 2030, with CAGR of around 7.02% during the period from 2025 to 2030.
Browse Report - Explore the report's contents, sections, and key insights by browsing through its detailed information: https://www.mordorintelligence.com/industry-reports/1-6-hexanediol-market?utm_source=openpr
The 1,6-hexanediol market refers to the global trade and use of 1,6-hexanediol, an organic chemical intermediate with two alcohol groups…
Wheat Flour Market Size to Reach USD 233.7 Billion by 2030, Supported by Bakery …
Wheat Flour Market Overview and Growth Outlook
The wheat flour market is valued at USD 190.3 billion in 2025 and is projected to reach USD 233.7 billion by 2030, growing at a CAGR of 4.19%. Growth is supported by urbanization, sustained demand for staple foods, and investments in advanced milling technologies such as energy-efficient roller mills and inline fortification systems. To manage climate-related supply risks, millers are diversifying sourcing and…
Automotive V2X Market Forecast to Reach USD 18.67 billion by 2030, Driven by Con …
Introduction
According to Mordor Intelligence, The Automotive V2X Market size is estimated at USD 2.87 billion in 2025, and is expected to reach USD 18.67 billion by 2030, at a CAGR of 45.43% during the forecast period (2025-2030), reflecting strong momentum across connected vehicle ecosystems. Governments, automakers, and technology providers are aligning around V2X communication as a foundation for safer and more coordinated transport systems.
Vehicle-to-everything communication enables vehicles…
Stadium Security Market Set to Reach USD 24.30 Billion by 2030 as AI Video Analy …
Mordor Intelligence has published a new report on the Stadium Security Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Stadium Security Market Overview
The stadium security market is entering a decisive growth phase as venue operators, governments, and sports bodies place stronger emphasis on crowd safety and risk control. According to Mordor Intelligence, the stadium security market size stood at USD 14.01 billion in 2025…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
